Clinical Trial Update: Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the combination of talimogene laherparepvec (Imlygic) and panitumumab (Vectibix) for locally advanced or metastatic squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Imlygic (Talimogene laherparepvec)
• Vectibix (panitumumab)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Locally Advanced Skin Squamous Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2024-01-18